Rozencweig M - Search Results

1

Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.

Rozencweig M, ten Bokkel Huinink W, Cavalli F, Bruntsch U, Dombernowsky P, Høst H, Bramwell V, Renard G, Van Glabbeke M, Decoster G. Rozencweig M, et al. J Clin Oncol. 1984 Apr;2(4):275-81. doi: 10.1200/JCO.1984.2.4.275. J Clin Oncol. 1984. PMID: 6584561 Clinical Trial.

2

Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).

Holdener EE, Hansen HH, Høst H, Bruntsch U, Cavalli F, Renard J, Pinedo HM, Rozencweig M. Holdener EE, et al. Among authors: rozencweig m. Invest New Drugs. 1985;3(1):63-6. doi: 10.1007/BF00176826. Invest New Drugs. 1985. PMID: 3857219

3

Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.

Høst H, Joss R, Pinedo H, Bruntsch U, Cavalli F, Renard G, van Glabbeke M, Rozencweig M. Høst H, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1983 Feb;19(2):295-8. doi: 10.1016/0277-5379(83)90430-3. Eur J Cancer Clin Oncol. 1983. PMID: 6681775

4

Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group.

De Jager R, Siegenthaler P, Cavalli F, Klepp O, Bramwell V, Joss R, Alberto P, van Glabbeke M, Renard J, Rozencweig M, Hansen HH. De Jager R, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1983 Feb;19(2):289-93. doi: 10.1016/0277-5379(83)90429-7. Eur J Cancer Clin Oncol. 1983. PMID: 6687457

5

Phase II evaluation of bisantrene in metastatic breast cancer.

Cavalli F, Gerard B, ten Bokkel Huinink W, Clavel M, Rozencweig M. Cavalli F, et al. Among authors: rozencweig m. Cancer Treat Rep. 1985 Mar;69(3):337-8. Cancer Treat Rep. 1985. PMID: 3978661 No abstract available.

6

N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group.

Bramwell V, Van Oosterom A, Mouridsen HT, Cheix F, Somers R, Thomas D, Rozencweig M. Bramwell V, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1982 Jan;18(1):81-4. doi: 10.1016/0277-5379(82)90029-3. Eur J Cancer Clin Oncol. 1982. PMID: 6211362

7

Phase II study of carminomycin in a human tumor cloning assay.

Rozencweig M, Sanders C, Rombaut W, Crespeigne N, Decoster G, Kenis Y, Klastersky J. Rozencweig M, et al. Invest New Drugs. 1984;2(3):267-70. doi: 10.1007/BF00175375. Invest New Drugs. 1984. PMID: 6511232

8

Phase II study of 9-hydroxy-2N-methylellipticinium acetate.

Clarysse A, Brugarolas A, Siegenthaler P, Abele R, Cavalli F, de Jager R, Renard G, Rozencweig M, Hansen HH. Clarysse A, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1984 Feb;20(2):243-7. doi: 10.1016/0277-5379(84)90190-1. Eur J Cancer Clin Oncol. 1984. PMID: 6538489

9

Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study.

Mulder JH, Dodion P, Cavalli F, Czarnetzki B, Clavel M, Thomas D, Suciu S, Rozencweig M. Mulder JH, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1982 Dec;18(12):1297-301. doi: 10.1016/0277-5379(82)90132-8. Eur J Cancer Clin Oncol. 1982. PMID: 6891928

10

Phase I study of triglycidylurazol given on a 5-day i.v. schedule.

Nicaise C, Rozencweig M, Crespeigne N, Dodion P, Gerard B, Lambert M, Decoster G, Kenis Y. Nicaise C, et al. Among authors: rozencweig m. Cancer Treat Rep. 1986 May;70(5):599-603. Cancer Treat Rep. 1986. PMID: 3708609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters